Beijing, China

Xiangbing Qi

This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Huahui Health Ltd., National Institute of Biological Sciences, Beijing, The University of Texas System. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiangbing Qi. Retrieved from https://idiyas.com/inventor/xiangbing-qi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 66.7

 

Average Co-Inventor Count = 7.5

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2019-2026

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Xiangbing Qi

Introduction

Xiangbing Qi is a prominent inventor based in Beijing, China. He has made significant contributions to the field of medical science, particularly in the development of innovative treatments for viral infections and metabolic disorders. With a total of two patents to his name, his work has the potential to impact the health and well-being of many individuals.

Latest Patents

Xiangbing Qi's latest patents include groundbreaking inventions. The first patent, titled "Polymeric bile acid derivatives inhibit Hepatitis B and D virus and NTCP transport," focuses on treating HBV or HDV infections. This invention provides a method for inhibiting the human sodium taurocholate co-transporting polypeptide (hNTCP) using a polymeric bile acid or its salt, along with pharmaceutical compositions that include a second HBV or HDV medicament. The second patent, "Inhibitors of mitochondrial pyruvate dehydrogenase kinase isoforms 1-4 and uses thereof," relates to the identification of PDK inhibitors. These inhibitors are designed for the treatment of diseases such as diabetes, cardiovascular disease, and cancer. The invention emphasizes the development of robust PDK inhibitors that enhance glucose metabolism and correct metabolic dysfunction in vivo.

Career Highlights

Xiangbing Qi has worked with notable organizations, including the University of Texas System and Huahui Health Ltd. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to significant advancements in medical research.

Collaborations

Some of his notable coworkers include David T Chuang and Shih-Chia Tso. Their collaborative efforts have further enriched the research environment and fostered innovation in their respective fields.

Conclusion

Xiangbing Qi's contributions to medical science through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for new treatments and advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…